Overview

Pharmacokinetic Drug-drug Interaction of CKD-330 and D086

Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is examining and comparing the pharmacokinetic drug interaction and safety of both single administration and combination administration of CKD-330 and D086 to healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical